Decentralised, point-of-care CAR-T for multiple myeloma

Lancet Oncol. 2023 Aug;24(8):828-830. doi: 10.1016/S1470-2045(23)00269-3. Epub 2023 Jul 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / drug therapy
  • Point-of-Care Systems
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen